FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

19504411000001105: Asenapine 5mg sublingual tablets sugar free (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66065301000001115 Asenapine 5mg sublingual tablets sugar free (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66065401000001111 Asenapine 5mg sublingual tablets sugar free en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Asenapine 5mg sublingual tablets sugar free Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletsublingual.oromucosal ontology form and route true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Sublingual route true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Is a Asenapine true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Is a Product containing asenapine false Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has active ingredient Asenapine false Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has specific active ingredient Asenapine maleate true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Asenapine true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has manufactured dose form Conventional release sublingual tablet false Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free Has basis of strength substance Asenapine false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sycrest 5mg sublingual tablets (Organon Pharma (UK) Ltd) Is a True Asenapine 5mg sublingual tablets sugar free Inferred relationship Existential restriction modifier
Asenapine 5mg sublingual tablets sugar free 60 tablet Has VMP True Asenapine 5mg sublingual tablets sugar free Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start